• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 TITANIUM LOW-PROFILE IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 TITANIUM LOW-PROFILE IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 0606150
Medical Device Problem Codes Fracture (1260); Material Separation (1562); Deformation Due to Compressive Stress (2889); Naturally Worn (2988); Migration (4003)
Health Effect - Clinical Codes Bacterial Infection (1735); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 11/26/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that five years, eleven months, and twenty-two days post a port placement, the catheter was allegedly fractured and migrated into the patient's right ventricle.Reportedly, the piece of catheter lodged in the heart was removed endovascularly.Evidently, the patient allegedly experienced bacterial infection.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.Investigation summary: one bardport titanium low-profile implantable port attached to a groshong catheter were returned for evaluation.Visual evaluation was performed on the returned device.Kinks were noted on the distal portion of the attached catheter.A complete circumferential break was noted on the distal end of the attached catheter.The edges of the circumferential break on the attached catheter were noted to be jagged, the surfaces were noted to be round and smooth in one region and granular in the other region.Therefore the investigation is confirmed for the reported fracture, material separation and the identified naturally worn and deformation issues.However the investigation is inconclusive for the reported migration issue as the exact circumstance at the time of the event reported was unknown and no evidence to confirm the reported migration was provided for review.Furthermore, the clinical conditions alleged in the complaint cannot be confirmed.The break is typical of flexural fatigue, which is due to the repetitive, cyclic kinking of the catheter.Such kinking may have physiological, placement, usage or mechanical contributing factors.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H11: section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that five years, eleven months, and twenty-two days post a port placement, the catheter was allegedly fractured and migrated into the patient's right ventricle.Reportedly, the piece of catheter lodged in the heart was removed endovascularly.Evidently, the patient allegedly experienced bacterial infection.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TITANIUM LOW-PROFILE IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F
Common Device Name
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key21051371
Report Number3006260740-2024-07990
Device Sequence Number13093854
Product Code LJT
UDI-Device Identifier00801741026058
UDI-Public(01)00801741026058(11)180207(17)230131(10)RECP0236
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K050310
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2023
Device Catalogue Number0606150
Device Lot NumberRECP0236
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/05/2024
Supplement Date Received by Manufacturer03/10/2025
Initial Report FDA Received Date01/01/2025
Supplement Report FDA Received Date03/17/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/07/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age70 YR
Patient SexUnknown
-
-